Aflac: An Insurer To Buy After Impressive Q1 Results, Even As Valuation Rises

Aflac remains a Buy despite a Q1 earnings miss, supported by organic policy growth, proven dividend increases, and robust balance sheet strength. Growth catalysts include new policy sales, expanding Asian market presence, and niche segments like pet insurance, though revenue trends remain uneven. Margins and expense ratios are favorable, with A-level credit ratings and conservative leverage, but forward P/E multiples signal some overvaluation and more muted near-term upside.

Seeking Alpha • May 6, 2026

Aflac Q1 Earnings Miss Estimates on Lower Investment Income

AFL misses Q1 estimates as lower investment income and FX pressure weigh on results, though U.S. sales strength and improved earnings partly offset the downside.

Zacks Investment Research • May 1, 2026

Aflac opens new South Portland office to support Maine Paid Family and Medical Leave Program

Company brings services closer to home for more than 500,000 workers COLUMBUS, Ga., May 1, 2026 /PRNewswire/ -- Working with the Maine Department of Labor and the state's Paid Family Medical Leave (PFML) Bureau, Aflac, the leading provider of supplemental health insurance in the U.S.1 and contracted administrator for the Maine PMFL program, announced the opening of a new office in South Portland, Maine.

PRNewsWire • May 1, 2026

Aflac CEO Dan Amos on building an American success story

Aflac CEO Dan Amos reflects on the company's rise from humble Southern roots to a $60 billion powerhouse — and the bold bet that defined his career: a “damn duck.”

CNBC Television • Apr 30, 2026

Aflac Incorporated (AFL) Q1 2026 Earnings Call Transcript

Aflac Incorporated (AFL) Q1 2026 Earnings Call Transcript

Seeking Alpha • Apr 30, 2026

Aflac Incorporated Announces First Quarter 2026 Results

COLUMBUS, Ga., April 29, 2026 /PRNewswire/ -- Aflac Incorporated (NYSE: AFL) today reported its first quarter results.

PRNewsWire • Apr 29, 2026

Aflac (AFL) Q1 Earnings and Revenues Miss Estimates

Aflac (AFL) came out with quarterly earnings of $1.75 per share, missing the Zacks Consensus Estimate of $1.8 per share. This compares to earnings of $1.66 per share a year ago.

Zacks Investment Research • Apr 29, 2026

Aflac (AFL) Reports Q1 Earnings: What Key Metrics Have to Say

Although the revenue and EPS for Aflac (AFL) give a sense of how its business performed in the quarter ended March 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Zacks Investment Research • Apr 30, 2026

Aflac recognizes 6 leaders as Check for Cancer Champions

This recognition is part of Aflac's broader Check for Cancer initiative to expand awareness of the importance of screening as the path for early detection COLUMBUS, Ga., April 29, 2026 /PRNewswire/ -- Aflac Incorporated, the leading provider of supplemental health insurance in the U.S.,1 is expanding its Check for Cancer initiative during Cancer Prevention and Early Detection Month by launching the Check for Cancer Champions program.

PRNewsWire • Apr 29, 2026

Aflac (AFL) Q1 Earnings on the Horizon: Analysts' Insights on Key Performance Measures

Get a deeper insight into the potential performance of Aflac (AFL) for the quarter ended March 2026 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.

Zacks Investment Research • Apr 28, 2026